Metabolic Effects of Empagliflozin in Heart Failure: A Randomized, Double-Blind, and Placebo-Controlled Trial (Empire HF Metabolic)

7 Citations (Scopus)
Original languageEnglish
JournalCirculation
Volume143
Issue number22
Pages (from-to)2208-2210
Number of pages3
ISSN0009-7322
DOIs
Publication statusPublished - 1 Jun 2021

Keywords

  • Body composition
  • Diabetes mellitus
  • Empagliflozin
  • Heart failure
  • Insulin resistance
  • Sodium-glucose transporter 2 inhibitors
  • Type 2

Cite this